Somatuline depot
| Somatuline depot | |
|---|---|
| Term | Somatuline depot |
| Short definition | Somatuline depot - (pronounced) (soh-MA-too-leen DEE-poh) drug similar to somatostatin (a hormone produced by the body) used to treat certain types of gastroenteropancreatic neuroendocrine tumors, carcinoid syndrome and acromegaly (a condition in which the pituitary gland produces too much growth hormone). Somatuline Depot can help prevent the body from producing extra amounts of certain hormones, including growth hormone, insulin, glucagon and hormones that affect digestion. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Somatuline depot - (pronounced) (soh-MA-too-leen DEE-poh) drug similar to somatostatin (a hormone produced by the body) used to treat certain types of gastroenteropancreatic neuroendocrine tumors, carcinoid syndrome and acromegaly (a condition in which the pituitary gland produces too much growth hormone). Somatuline Depot can help prevent the body from producing extra amounts of certain hormones, including growth hormone, insulin, glucagon and hormones that affect digestion. It can also help prevent certain types of tumor cells from growing. Somatuline Depot is a type of somatostatin analogue. Also called lanreotide acetate
External links
- Medical encyclopedia article on Somatuline depot
- Wikipedia's article - Somatuline depot
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski